Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 16, 2020 (7 years ago)

nICARdipine HCl

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

nICARdipine HCl (0.1 mg/mL) 1 mg/10mL, in 0.9% Sodium Chloride Injection USP, 10 ml in a 20mL syringe, Rx Only, PharMEDium Services LLC 12620 W. Airport Boulevard #130 Sugar Land, TX 77470. NDC 71019-206-01

Affected NDC 71019-0206-01

Compare with the code on your package — it is the most precise check available.

Drug: Nicardipine

Recalling firm
PharMEDium Services, LLC
NDC code
71019-206-01
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1082-2020 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Nicardipine recalls

See all
Class II · Moderate risk

Cardene IV

CGMP Deviations

Ongoing cGMP deviation Baxter Healthcare Corporation NDC 43066-016-10 D-0813-2026

Other recalls by PharMEDium Services, LLC

All 2020 recalls